JAZZ - Jazz Pharmaceuticals plc

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 136.06

Open

$ 134.42

Bid

$ 131.00 x 50

Ask

$ 140.00 x 11

Day's Range

$ 133.41 - $ 136.61

52 Week Range

$ 95.49 - $ 148.06

Volume

367,722

Average Volume

Market Cap

8.25B

Beta (5Y Monthly)

$ 0.61

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2025	06-30-2025	10-Q
2	05-07-2025	03-31-2025	10-Q
3	02-26-2025	12-31-2024	10-K
4	11-07-2024	09-30-2024	10-Q
5	08-01-2024	06-30-2024	10-Q
6	05-02-2024	03-31-2024	10-Q
7	02-28-2024	12-31-2023	10-K
8	11-08-2023	09-30-2023	10-Q
9	08-09-2023	06-30-2023	10-Q
10	05-10-2023	03-31-2023	10-Q
11	03-01-2023	12-31-2022	10-K
12	11-09-2022	09-30-2022	10-Q
13	08-03-2022	06-30-2022	10-Q
14	05-04-2022	03-31-2022	10-Q
15	03-01-2022	12-31-2021	10-K
16	11-09-2021	09-30-2021	10-Q
17	08-03-2021	06-30-2021	10-Q
18	05-04-2021	03-31-2021	10-Q
19	02-23-2021	12-31-2020	10-K
20	11-02-2020	09-30-2020	10-Q
21	08-04-2020	06-30-2020	10-Q
22	05-05-2020	03-31-2020	10-Q
23	02-25-2020	12-31-2019	10-K
24	11-05-2019	09-30-2019	10-Q
25	08-06-2019	06-30-2019	10-Q
26	05-07-2019	03-31-2019	10-Q
27	02-26-2019	12-31-2018	10-K
28	11-06-2018	09-30-2018	10-Q
29	08-07-2018	06-30-2018	10-Q
30	05-08-2018	03-31-2018	10-Q
31	02-27-2018	12-31-2017	10-K
32	11-07-2017	09-30-2017	10-Q
33	08-08-2017	06-30-2017	10-Q
34	05-09-2017	03-31-2017	10-Q
35	02-28-2017	12-31-2016	10-K
36	11-08-2016	09-30-2016	10-Q
37	08-09-2016	06-30-2016	10-Q
38	05-10-2016	03-31-2016	10-Q
39	02-23-2016	12-31-2015	10-K
40	11-09-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

3-small-cap-stocks-to-play-as-the-bantamweights-break-out-on-wall-street

3 Small Cap Stocks To Play As The Bantamwe...
10/17/2025 17:47:30

scisparc-expands-biotech-ambitions-buys-stake-in-miza-iii-ventures

SciSparc Expands Biotech Ambitions, Buys S...
10/15/2025 13:34:30

SciSparc traded higher after the company announced it had signed a definitive agreement to acquire a controlling stake in Miza ...

SciSparc And AutoMax Call Off Merger
10/06/2025 12:55:03

SciSparc ends merger with AutoMax, sets loan repayment terms, and refocuses on CNS drug development and innovation.

FDA Approves Lurbinectedin In Combination ...
10/02/2025 19:35:24

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-lurbinectedin-combination-atezolizumab-or-atezolizu...

Deep Dive Into Jazz Pharmaceuticals Stock:...
09/24/2025 14:01:57

Morgan Stanley Maintains Overweight on Jaz...
09/24/2025 13:25:43

Morgan Stanley analyst Jeffrey Hung maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and raises the price targ...

Jazz Pharma's Xywav Shows Phase 4 Results ...
09/22/2025 11:46:31

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced new real-world evidence and Phase 4 data reinforcing the value of Xywav...

Court Orders Avadel CNS To Pay 3.85% Ongoi...
09/17/2025 15:57:16

As previously disclosed, on May 12, 2021, Jazz Pharmaceuticals, Inc. ("Jazz") filed a formal complaint initiating a law...

Jazz Pharma's Modeyso Earns NCCN Category ...
09/09/2025 11:48:52

Modeyso, the first treatment option for this ultra-rare and aggressive brain tumor, is commercially available in the United Sta...

Goldman Sachs Maintains Buy on Jazz Pharma...
08/29/2025 17:40:13

Goldman Sachs analyst Madhu Kumar maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and raises the price target from $...

Morgan Stanley Maintains Overweight on Jaz...
08/28/2025 16:15:46

Morgan Stanley analyst Jeffrey Hung maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and raises the price targ...

RBC Capital Maintains Outperform on Jazz P...
08/28/2025 13:32:13

RBC Capital analyst Leonid Timashev maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Outperform and raises the price targ...

Truist Securities Maintains Buy on Jazz Ph...
08/28/2025 12:55:20

Truist Securities analyst Gregory Fraser maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and raises the price target...

Needham Reiterates Buy on Jazz Pharmaceuti...
08/28/2025 11:09:04

Needham analyst Ami Fadia reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and maintains $202 price target.

Beyond The Numbers: 5 Analysts Discuss Jaz...
08/20/2025 14:01:01

Needham Reiterates Buy on Jazz Pharmaceuti...
08/20/2025 13:09:47

Needham analyst Ami Fadia reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and maintains $202 price target.

Jazz Pharmaceuticals Strikes $1B-Plus Deal...
08/20/2025 11:34:02

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) and Saniona (Nasdaq OMX: SANION) today announce that the companies have entered into a g...

FDA Grants Accelerated Approval To Dordavi...
08/06/2025 18:28:24

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-dordaviprone-diffuse-midline-glioma

Morgan Stanley Maintains Overweight on Jaz...
08/06/2025 16:22:48

Morgan Stanley analyst Jeffrey Hung maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and lowers the price targ...

Jazz Pharmaceuticals Names Renee Gala As P...
08/05/2025 21:16:39

3 Small Cap Stocks To Play As The Bantamwe...
10/17/2025 17:47:30